1. Home
  2. OMH vs CELU Comparison

OMH vs CELU Comparison

Compare OMH & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

HOLD

Current Price

$1.48

Market Cap

32.6M

Sector

Finance

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.25

Market Cap

34.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMH
CELU
Founded
2015
2016
Country
Singapore
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.6M
34.5M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
OMH
CELU
Price
$1.48
$1.25
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
157.3K
34.7K
Earning Date
11-28-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,264,748.00
$40,578,000.00
Revenue This Year
$28.40
N/A
Revenue Next Year
$23.07
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
78.86
N/A
52 Week Low
$0.59
$1.00
52 Week High
$4.46
$4.35

Technical Indicators

Market Signals
Indicator
OMH
CELU
Relative Strength Index (RSI) 58.31 46.57
Support Level $1.17 $1.17
Resistance Level $1.29 $1.33
Average True Range (ATR) 0.20 0.07
MACD -0.02 0.01
Stochastic Oscillator 56.96 56.25

Price Performance

Historical Comparison
OMH
CELU

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: